The minimal clinical important difference in the World Health Organization Quality of Life instrument - 100

Supportive Care in Cancer

Volumn 21, Issue 5, 2013, Pages 1295-1301

  Den Oudsten, Brenda L ^a,b   Zijlstra, Wobbe P ^a   De Vries, Jolanda ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b TweeSteden Hospital   (Netherlands)

Author keywords

Breast cancer; Distribution based methods; Minimal important difference; Quality of life; WHOQOL 100

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER STAGING; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; FAMILY SIZE; FEMALE; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MARRIAGE; MEASUREMENT ERROR; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; STATE TRAIT ANXIETY INVENTORY; WORLD HEALTH ORGANIZATION QUALITY OF LIFE INSTRUMENT 100;

ADULT; AGED; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; QUALITY OF LIFE; WORLD HEALTH ORGANIZATION;

EID: 84879689447     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1664-8     Document Type: Article

References (33)

1. WHOQOL group (1995) The World Health Organization Quality of Life assessment [WHOQOL]: position paper from the World Health Organization. Soc Sci Med 41:1403-1409
2. WHOQOL Group (1998) The World Health Organization Quality of Life Assessment [WHOQOL]: development and general psychometric properties. Soc Sci Med 46:1569-1585
3. Tazaki M, Nakane Y, Endo T, Kakikawa F, Kano K, Kawano H et al (1998) Results of a qualitative and field study using the WHOQOL instrument for cancer patients. Jpn J Clin Oncol 28:134-141
4. Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De Vries J (2009) The WHOQOL-100 has good psychometric properties in breast cancer patients. J Clin Epidemiol 62(2):195-205
5. O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC (2000) A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res 9:121-124
6. O'Carroll RE, Couston M, Cossar J, Masterton G, Hayes PC (2003) Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl 9:712-720
7. Skevington SM, Carse MS, Williams AC (2001) Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain 17:264-275
8. Masthoff ED, Trompenaars FJ, Van Heck GL, Hodiamont PP, De Vries J (2005) Validation of the WHO Quality of Life assessment instrument [WHOQOL-100] in a population of Dutch adult psychiatric outpatients. Eur Psychiatry 20:465-473
9. Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102-109
10. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T (2002) Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 77(4):367-370
11. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK (2006) Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 4:70
12. De Vries J, Van Heck GL (1997) The World Health Organization Quality of Life assessment instrument [WHOQOL-100]: validation study with the Dutch version. Eur J Psychol Assess 13:164-178
13. Guyatt G, Schunemann H (2007) How can quality of life researchers make their work more useful to health workers and their patients? Qual Life Res 16(7):1097-1105
14. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582-592
15. Norman GR, Sloan JA, Wyrwich KW (2004) The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Rev Pharmacoecon Outcomes Res 4(5):581-585
16. Crosby RD, Kolotkin RL, Williams GR (2003) Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 56(5):395-407
17. Bonomi AE, Patrick DL, Bushnell DM, Martin M (2000) Validation of the United States' version of the World Health Organization Quality of Life [WHOQOL] instrument. J Clin Epidemiol 53(1):1-12
18. O'Carroll RE, Cossar JA, Couston MC, Hayes PC (2000) Sensitivity to change following liver transplantation: a comparison of three instruments that measure quality of life. J Health Psychol 5:69-74
19. van der Steeg AF, De Vries J, Roukema JA (2010) Anxious personality and breast cancer: possible negative impact on quality of life after breast-conserving therapy. World J Surg 34(7):1453-1460
20. Van der Steeg AF, De Vries J, Van der Ent FW, Roukema JA (2007) Personality predicts quality of life six months after the diagnosis and treatment of breast disease. Ann Surg Oncol 14:678-685
21. Power M, Harper A, Bullinger M (1999) The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide. Health Psychol 18:495-505
22. WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 28:551-558
23. Spielberger CD, Gorsuch RL, Lushene RE (1970) STAI manual for the State-Trait Anxiety Inventory. Consulting Psychologists, Palo Alto
24. Van der Ploeg HM, Defares PB, Spielberger CD (1980) ZBV: a Dutch-language adaptation of the Spielberger State-Trait Anxiety Inventory. Swets & Zeitlinger, Lisse
25. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC (2007) Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7(5):541-546
26. Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59(1):12-19
27. Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861-873
28. Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ et al (2005) Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal [FACT-C] instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol 58(12):1241-1251
29. Juniper EF, Guyatt GH, Willan A, Griffith LE (1994) Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47(1):81-87
30. Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10(4):407-415
31. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy [FACT] anemia and fatigue scales. J Pain Symptom Manag 24(6):547-561
32. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, Hillsdale
33. King MT (2011) A point of minimal important difference [MID]: a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171-184